A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques

Journal of General Virology

Volumn 83, Issue 1, 2002, Pages 75-80

  Wee, E G T ^a   Patel, S ^a   McMichael, A J ^a   Hanke, T ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; EPITOPE; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; PEPTIDE; PLASMID DNA; RECOMBINANT DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; KENYA; MOUSE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE; VACCINE PRODUCTION; VACCINIA VIRUS; VIRUS ISOLATION; VIRUS NEUTRALIZATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; MACACA; MACACA MULATTA; PRIMATES; RNA VIRUSES; VACCINIA VIRUS;

EID: 0036135692     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-1-75     Document Type: Article

References (43)

1. *01) that binds an immunodominant CTL epitope from SIV
2. Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen
3. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine
4. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
5. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity
6. Virus-specific CD8+ CTL activity associated with control of viremia in primary HIV-1 infection
7. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus
8. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge
9. Early suppression of SIV replication by CD8 + nef-specific cytotoxic T cells in vaccinated animals
10. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
11. Dynamics of viral variants in HIV-1 Nef and specific cytotoxic T lymphocytes in vivo
12. Prospect of a prophylactic vaccine for HIV
13. Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya
14. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime
15. DNA multi-CTL epitope vaccines for HIV and Plasmodium falciparum: Immunogenicity in mice
16. Effective induction of HIV-specific CTL by multi-epitope DNA using a gene gun in a combined vaccination regime
17. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen
18. +T cell depletion in simian immunodeficiency virus-infected macaques
19. Human immunodeficiency virus type 1 (HIV-1)-specific T cell responses correlate with the control of acute HIV-1 infection in macaques
20. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus
21. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression
22. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
23. Identification of functional subsets by flow cytometry: Intracellular detection of cytokine expression
24. CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection
25. Definition of an epitope and MHC class I molecule recognized by Gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys
26. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition
27. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
28. Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes
29. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
30. Characterization of HIV-1-specific T-helper cells in acute and chronic infection
31. Immune responses in HIV-exposed seronegatives: Have they repelled the virus?
32. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes
33. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara
34. + cell noncytotoxic anti-HIV response
35. Detection of antigen-specific T cell cytokine expression in whole blood by flow cytometry
36. A re-evaluation of the frequency of CD8+ T cells specific for EBV in healthy virus carriers
37. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge
38. Beta-chemokines are released from HIV-1-specific cytolytic T cell granules complexed to proteoglycans
39. Frequent detection of escape from cytotoxic T-lymphocyte recognition in perinatal human immunodeficiency virus (HIV) type 1 transmission: The Ariel Project for the prevention of transmission of HIV from mother to infant
40. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection
41. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection
42. Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: Evidence for HLA class 1-restricted triggering of cytolytic and noncytolytic mechanisms
43. Protective immunity to HIV-1 in SCID/beige mice reconstituted with peripheral blood lymphocytes of exposed but uninfected individuals